Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-06

Clinical Trial Update: A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics of BMS-986177 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of rifampin on the single-dose pharmacokinetics of BMS-986177 in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BMS-986177
  • RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Thrombosis | Phase 1 | Status: COMPLETED